Overview of What You Will Learn
This ACPE-accredited webinar will guide you through reviewing a Medicare Cost Report (MCR), its corresponding Trial Balance (TB), and creating a 340B Location Crosswalk. You’ll understand how these documents are utilized by HRSA to determine 340B hospital location eligibility and what documents are requested during HRSA audits.
Our expert speakers, Greg Wilson, PharmD, BCPS, 340B ACE; Catherine Eriksen, 340B ACE; and Rob Nahoopii, PharmD, MS, 340B ACE from SpendMend, will share their extensive knowledge and deep insights on these topics.
This webinar is for Pharmacists and Technicians seeking to deepen their understanding of HRSA audits, 340B hospital location eligibility, and related documentation.
Pharmacists’ Objectives:
- Understand how the Medicare Cost Report (MCR) and Trial Balance (TB) are utilized by HRSA to determine 340B hospital location eligibility.
- Identify documents requested during HRSA audits to validate the eligibility of hospital locations.
- Demonstrate the process for creating an MCR, TB, and Location crosswalk.
Technicians’ Objectives:
- Understand how the Medicare Cost Report (MCR) and Trial Balance (TB) are utilized by HRSA to determine 340B hospital location eligibility.
- Identify documents requested during HRSA audits to validate the eligibility of hospital locations.
- Demonstrate the process for creating an MCR, TB, and Location crosswalk.
In addition to the knowledge gained attendees of this webinar will earn Continuing Education (CE) credits. These credits will contribute to your professional development and help you stay current in your field while enhancing your understanding of 340B Program compliance.
Watch the Webinar
About the Speakers
Greg Wilson
PharmD, BCPS, 340B ACE
Greg Wilson, PharmD, BCPS, 340B ACE, is a Director of Compliance for SpendMend. In this role, he oversees independent external audits and provides covered entity support during the HRSA audit process. He has more than 15 years of health care experience serving in a variety of roles in hospital and health system pharmacy. Prior to joining SpendMend, he was the director of corporate pharmacy services for a large integrated delivery network based in Pittsburgh, PA, with responsibility for formulary management, medication-use policy, coordination of system-level P&T Committee activities, and oversight of 340B Program compliance and optimization.
Cat Eriksen
340B ACE
Cat Eriksen, 340B ACE, is a Pharmacy Professional Services Coordinator at SpendMend Pharmacy. In this role, she oversees the development, implementation, monitoring, and delivery of SpendMend Pharmacy Support Services. She also conducts independent external audits and provides covered entity support during the HRSA audit process. Cat has direct 340B experience as a former Pharmacy Business Manager at a district hospital in Central California. Her responsibilities included non-clinical inpatient and outpatient pharmacy support and planning, oversight, and direct responsibility for a 340B program for a 600+-bed (DSH) hospital, two in-house retail pharmacies, and contract pharmacy arrangements.
Rob Nahoopii
PharmD, MS, ACE
Rob has frontline 340B experience as a regional director of pharmacy within a 22-hospital Health-system. His responsibilities included regional oversight, and direct responsibility for a 395-bed DSH (DISH) hospital, in-house community pharmacy, and contract pharmacy arrangements. For the last 9 years, he has been providing 340B external independent audits and 340B gap analyses for 340B covered entities across the country through his role as CEO of Turnkey Pharmacy Solutions, and after Turnkey’s acquisition by SpendMend, as SVP of Pharmacy Services. Rob has personally conducted over 300 independent 340B audits for covered entities and has supported over 25 HRSA 340B audits for clients. Rob has served on the Apexus DSH council and was a 340B University faculty member for over 3 years.